The inhibition test required patients to press the spacebar at the smiling face but withhold at the winking face. Finally, the anticipation test required patients to press the spacebar when 2 footballs moving across the computer screen collided.2
Faster reaction times during ovulation
There were 54 participants aged a mean of 28 ± 6 years included in the final analysis. The mean body mass index was 23.6 ± 4.4, and the average cycle length was 29 ± 2 days in these patients. These characteristics did not significantly differ between groups. Recreational sport participation was reported by 20 participants.2
During ovulation, faster reactions were reported on the attention and inhibition battery. However, slower reaction times were reported during the mid-luteal phase, and more errors occurred during the late follicular phase. Additionally, slower reaction times and more errors were reported in inactive vs active patients.2
A main effect of phase F(3,150) = 4.53 indicated faster reaction times during ovulation. For active participants, a main effect of F(3,50) = 3.80 was reported. During group by phase interaction, only elite participants had faster reaction times during ovulation vs other phases and slower reaction times during the mid-luteal phase. Reaction times included:
- 482 ± 81 ms for the sustained attention task during ovulation
- 390 ± 69 ms for the inhibition task during ovulation
- 531 ± 138 ms for the sustained attention task during the mid-luteal phase
- 430 ± 127 for the inhibition task during the mid-luteal phase
Overall, the results indicated improved cognitive performance during ovulation. However, athletic participation had a greater effect on cognitive outcomes vs the menstrual phase.2
“Working exercise into our day doesn’t need to be difficult. Some of our previous studies have shown that 15 minutes of moderate activity is enough to boost our mood and cognitive performance, that is equivalent to taking a brisk walk around the block or cycling to the shops,” said Ronca.1
Hormonal treatment for menstrual symptoms
Menstrual symptoms also impact other aspects of quality of life, but a phase 3 trial published in April 2025 highlighted the efficacy of an estetrol pill toward easing these symptoms.3 Patients were either starters, defined as not using hormonal contraception prior to the study, or switchers, defined as transitioning from another hormonal contraceptive.
Symptom intensity across pain, water retention, and negative affect domains were significantly reduced among starters, while relief remained stable among switchers. Additionally, many symptoms such as cramps, headaches, back pain, fatigue, swelling, tender breasts, anxiety, and irritability showed at least a 40% reduction in severity.3
“So even in those switchers, there’s a definite ability of the product to have a significant impact for people,” said Mitchell Creinin, MD, professor at the University of California Davis Health.3